Immune senescence and vaccines to prevent herpes zoster in older persons
Highlights ► Latent VZV is maintained in sensory neurons because of VZV-specific T-cell immunity. ► This immunity declines with age – the number/function of early effectors and effector memory. ► The loss of this T-cell immunity correlates with the occurrence of herpes zoster. ► A herpes zoster vacc...
Gespeichert in:
Veröffentlicht in: | Current opinion in immunology 2012-08, Vol.24 (4), p.494-500 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 500 |
---|---|
container_issue | 4 |
container_start_page | 494 |
container_title | Current opinion in immunology |
container_volume | 24 |
creator | Levin, Myron J |
description | Highlights ► Latent VZV is maintained in sensory neurons because of VZV-specific T-cell immunity. ► This immunity declines with age – the number/function of early effectors and effector memory. ► The loss of this T-cell immunity correlates with the occurrence of herpes zoster. ► A herpes zoster vaccine can restore this immunity and prevent herpes zoster. ► Suggestions are offered to improve the efficacy of zoster vaccine. |
doi_str_mv | 10.1016/j.coi.2012.06.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1034514038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952791512000957</els_id><sourcerecordid>1034514038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-5928c783ab6693f0b7c1ad892c940b92a9957eb5141bc9aeed3dc25ab3e6a913</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpaTZpf0Auxcde7I6klW1RCISlbQKBHpq7kOVZqo0tuZK9kPz6jNm0hxx6GjG89xh9j7FLDhUHXn85VC76SgAXFdQVgHjDNrxtdAmyEW_ZBrQSZaO5OmPnOR8AQCkJ79mZEK1qWiE37OZ2HJeARcaA2WFwWNjQF0frnKdNMcdiSnjEMBe_MU20eYp5xlT4UMShp8eEKceQP7B3eztk_PgyL9j992_3u5vy7ueP2931Xem20M6l0qJ1TSttV9da7qFrHLd9q4XTW-i0sFqrBjvFt7xz2iL2sndC2U5ibTWXF-zzKXZK8c-CeTajp7uHwQaMSzYc5JbMIFuS8pPUpZhzwr2Zkh9teiSRWfmZgyF-ZuVnoDbEjzyfXuKXbsT-n-MvMBJ8PQmQ_nj0mEx2fsXW-4RuNj0F_i_-6pXbDT54Z4cHfMR8iEsKBM9wk8ljfq0Frv1xQd0RGPkMcCqVUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1034514038</pqid></control><display><type>article</type><title>Immune senescence and vaccines to prevent herpes zoster in older persons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Levin, Myron J</creator><creatorcontrib>Levin, Myron J</creatorcontrib><description>Highlights ► Latent VZV is maintained in sensory neurons because of VZV-specific T-cell immunity. ► This immunity declines with age – the number/function of early effectors and effector memory. ► The loss of this T-cell immunity correlates with the occurrence of herpes zoster. ► A herpes zoster vaccine can restore this immunity and prevent herpes zoster. ► Suggestions are offered to improve the efficacy of zoster vaccine.</description><identifier>ISSN: 0952-7915</identifier><identifier>EISSN: 1879-0372</identifier><identifier>DOI: 10.1016/j.coi.2012.06.002</identifier><identifier>PMID: 22857823</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Aging - immunology ; Allergy and Immunology ; Animals ; Herpes Zoster - prevention & control ; Herpes Zoster Vaccine - immunology ; Herpesvirus 3, Human - immunology ; Humans ; Immunity, Cellular - physiology ; T-Lymphocytes - immunology</subject><ispartof>Current opinion in immunology, 2012-08, Vol.24 (4), p.494-500</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-5928c783ab6693f0b7c1ad892c940b92a9957eb5141bc9aeed3dc25ab3e6a913</citedby><cites>FETCH-LOGICAL-c408t-5928c783ab6693f0b7c1ad892c940b92a9957eb5141bc9aeed3dc25ab3e6a913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0952791512000957$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22857823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Levin, Myron J</creatorcontrib><title>Immune senescence and vaccines to prevent herpes zoster in older persons</title><title>Current opinion in immunology</title><addtitle>Curr Opin Immunol</addtitle><description>Highlights ► Latent VZV is maintained in sensory neurons because of VZV-specific T-cell immunity. ► This immunity declines with age – the number/function of early effectors and effector memory. ► The loss of this T-cell immunity correlates with the occurrence of herpes zoster. ► A herpes zoster vaccine can restore this immunity and prevent herpes zoster. ► Suggestions are offered to improve the efficacy of zoster vaccine.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - immunology</subject><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Herpes Zoster - prevention & control</subject><subject>Herpes Zoster Vaccine - immunology</subject><subject>Herpesvirus 3, Human - immunology</subject><subject>Humans</subject><subject>Immunity, Cellular - physiology</subject><subject>T-Lymphocytes - immunology</subject><issn>0952-7915</issn><issn>1879-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFr3DAQhUVpaTZpf0Auxcde7I6klW1RCISlbQKBHpq7kOVZqo0tuZK9kPz6jNm0hxx6GjG89xh9j7FLDhUHXn85VC76SgAXFdQVgHjDNrxtdAmyEW_ZBrQSZaO5OmPnOR8AQCkJ79mZEK1qWiE37OZ2HJeARcaA2WFwWNjQF0frnKdNMcdiSnjEMBe_MU20eYp5xlT4UMShp8eEKceQP7B3eztk_PgyL9j992_3u5vy7ueP2931Xem20M6l0qJ1TSttV9da7qFrHLd9q4XTW-i0sFqrBjvFt7xz2iL2sndC2U5ibTWXF-zzKXZK8c-CeTajp7uHwQaMSzYc5JbMIFuS8pPUpZhzwr2Zkh9teiSRWfmZgyF-ZuVnoDbEjzyfXuKXbsT-n-MvMBJ8PQmQ_nj0mEx2fsXW-4RuNj0F_i_-6pXbDT54Z4cHfMR8iEsKBM9wk8ljfq0Frv1xQd0RGPkMcCqVUA</recordid><startdate>20120801</startdate><enddate>20120801</enddate><creator>Levin, Myron J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120801</creationdate><title>Immune senescence and vaccines to prevent herpes zoster in older persons</title><author>Levin, Myron J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-5928c783ab6693f0b7c1ad892c940b92a9957eb5141bc9aeed3dc25ab3e6a913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - immunology</topic><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Herpes Zoster - prevention & control</topic><topic>Herpes Zoster Vaccine - immunology</topic><topic>Herpesvirus 3, Human - immunology</topic><topic>Humans</topic><topic>Immunity, Cellular - physiology</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levin, Myron J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levin, Myron J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune senescence and vaccines to prevent herpes zoster in older persons</atitle><jtitle>Current opinion in immunology</jtitle><addtitle>Curr Opin Immunol</addtitle><date>2012-08-01</date><risdate>2012</risdate><volume>24</volume><issue>4</issue><spage>494</spage><epage>500</epage><pages>494-500</pages><issn>0952-7915</issn><eissn>1879-0372</eissn><abstract>Highlights ► Latent VZV is maintained in sensory neurons because of VZV-specific T-cell immunity. ► This immunity declines with age – the number/function of early effectors and effector memory. ► The loss of this T-cell immunity correlates with the occurrence of herpes zoster. ► A herpes zoster vaccine can restore this immunity and prevent herpes zoster. ► Suggestions are offered to improve the efficacy of zoster vaccine.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22857823</pmid><doi>10.1016/j.coi.2012.06.002</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0952-7915 |
ispartof | Current opinion in immunology, 2012-08, Vol.24 (4), p.494-500 |
issn | 0952-7915 1879-0372 |
language | eng |
recordid | cdi_proquest_miscellaneous_1034514038 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Aged Aged, 80 and over Aging - immunology Allergy and Immunology Animals Herpes Zoster - prevention & control Herpes Zoster Vaccine - immunology Herpesvirus 3, Human - immunology Humans Immunity, Cellular - physiology T-Lymphocytes - immunology |
title | Immune senescence and vaccines to prevent herpes zoster in older persons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A44%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20senescence%20and%20vaccines%20to%20prevent%20herpes%20zoster%20in%20older%20persons&rft.jtitle=Current%20opinion%20in%20immunology&rft.au=Levin,%20Myron%20J&rft.date=2012-08-01&rft.volume=24&rft.issue=4&rft.spage=494&rft.epage=500&rft.pages=494-500&rft.issn=0952-7915&rft.eissn=1879-0372&rft_id=info:doi/10.1016/j.coi.2012.06.002&rft_dat=%3Cproquest_cross%3E1034514038%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1034514038&rft_id=info:pmid/22857823&rft_els_id=S0952791512000957&rfr_iscdi=true |